Addex Therapeutics Ltd (ADXN)
8.78
-0.01
(-0.11%)
USD |
NASDAQ |
May 17, 16:00
8.78
0.00 (0.00%)
After-Hours: 18:45
Addex Therapeutics Market Cap: 9.384M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 9.395M |
| May 15, 2024 | 9.619M |
| May 14, 2024 | 10.10M |
| May 13, 2024 | 9.972M |
| May 10, 2024 | 9.983M |
| May 09, 2024 | 9.566M |
| May 08, 2024 | 9.619M |
| May 07, 2024 | 9.780M |
| May 06, 2024 | 9.780M |
| May 03, 2024 | 9.566M |
| May 02, 2024 | 9.459M |
| May 01, 2024 | 8.668M |
| April 30, 2024 | 8.176M |
| April 29, 2024 | 8.059M |
| April 26, 2024 | 17.21M |
| April 25, 2024 | 16.47M |
| April 24, 2024 | 16.62M |
| April 23, 2024 | 20.03M |
| April 22, 2024 | 20.61M |
| April 19, 2024 | 21.43M |
| April 18, 2024 | 22.40M |
| April 17, 2024 | 23.51M |
| April 16, 2024 | 24.15M |
| April 15, 2024 | 26.45M |
| April 12, 2024 | 27.33M |
| Date | Value |
|---|---|
| April 11, 2024 | 27.95M |
| April 10, 2024 | 29.11M |
| April 09, 2024 | 29.82M |
| April 08, 2024 | 23.35M |
| April 05, 2024 | 19.10M |
| April 04, 2024 | 17.51M |
| April 03, 2024 | 16.46M |
| April 02, 2024 | 14.15M |
| April 01, 2024 | 13.89M |
| March 28, 2024 | 13.68M |
| March 27, 2024 | 13.20M |
| March 26, 2024 | 12.88M |
| March 25, 2024 | 12.61M |
| March 22, 2024 | 12.53M |
| March 21, 2024 | 12.93M |
| March 20, 2024 | 13.04M |
| March 19, 2024 | 12.86M |
| March 18, 2024 | 12.80M |
| March 15, 2024 | 12.52M |
| March 14, 2024 | 11.98M |
| March 13, 2024 | 11.81M |
| March 12, 2024 | 12.50M |
| March 11, 2024 | 12.57M |
| March 08, 2024 | 12.29M |
| March 07, 2024 | 10.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.324M
Minimum
Nov 09 2023
106.92M
Maximum
Dec 24 2020
30.52M
Average
30.00M
Median
Apr 01 2020
Market Cap Benchmarks
| AC Immune SA | 317.47M |
| CRISPR Therapeutics AG | 4.772B |
| NLS Pharmaceutics Ltd | 6.641M |
| Molecular Partners AG | 127.15M |
| MoonLake Immunotherapeutics | 2.499B |
Market Cap Related Metrics
| PS Ratio | 3.041 |
| Price to Book Value | 6.881 |
| Price | 8.78 |
| Earnings Yield | -212.5% |